Ophthalmology

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Review top news and interview highlights from the week ending November 18, 2022.

Editas has paused enrollment in the BRILLIANCE trial after efficacy was only seen in a very small subset of patients.